Bifidobacterium infantis EVC001
Selected indexed studies
- Bifidobacteria-mediated immune system imprinting early in life. (Cell, 2021) [PMID:34143954]
- Bifidobacterium longum Subspecies infantis Strain EVC001 Decreases Neonatal Murine Necrotizing Enterocolitis. (Nutrients, 2022) [PMID:35276854]
- Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants. (mSphere, 2017) [PMID:29242832]
_Worker-drafted node — pending editorial review._
Connections
Bifidobacterium infantis EVC001 helps
Sources
- Bifidobacteria-mediated immune system imprinting early in life. (2021) pubmed
- Bifidobacterium longum Subspecies infantis Strain EVC001 Decreases Neonatal Murine Necrotizing Enterocolitis. (2022) pubmed
- Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants. (2017) pubmed
- Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol. (2021) pubmed
- Bifidobacterium infantis treatment promotes weight gain in Bangladeshi infants with severe acute malnutrition. (2022) pubmed
- Bifidobacterium longum subsp infantis (EVC001) is associated with reduced incidence of necrotizing enterocolitis stage ≥2 and bloody stools in premature babies. (2025) pubmed
- Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants. (2019) pubmed
- Symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 probiotic in infants: results from a consumer survey on the effects on diaper rash, colic symptoms, and sleep. (2021) pubmed
- Reduced colonic mucin degradation in breastfed infants colonized by Bifidobacterium longum subsp. infantis EVC001. (2018) pubmed
- Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial. (2017) pubmed